21 CFR 343.13 - Rheumatologic active ingredients.
(b) Buffered aspirin. Aspirin identified in paragraph (a) of this section may be buffered with any antacid ingredient(s) identified in § 331.11 of this chapter provided that the finished product contains at least 1.9 milliequivalents of acid-neutralizing capacity per 325 milligrams of aspirin as measured by the procedure provided in the United States Pharmacopeia 23/National Formulary 18.
Title 21 published on 2014-04-01.
No entries appear in the Federal Register after this date, for 21 CFR Part 343.